|
Volumn 42, Issue 4, 2003, Pages 600-601
|
Dose reduction of etanercept - Can we treat more patients using a fixed budget? [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
ETANERCEPT;
INFLIXIMAB;
ADULT;
BUDGET;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG COST;
DRUG USE;
FEMALE;
HUMAN;
JOINT RADIOGRAPHY;
LETTER;
MALE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
TREATMENT OUTCOME;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 0037385995
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: 10.1093/rheumatology/keg135 Document Type: Letter |
Times cited : (10)
|
References (6)
|